Correlation Between Salesforce and Pulse Biosciences

Can any of the company-specific risk be diversified away by investing in both Salesforce and Pulse Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Pulse Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salesforce and Pulse Biosciences, you can compare the effects of market volatilities on Salesforce and Pulse Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Pulse Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Pulse Biosciences.

Diversification Opportunities for Salesforce and Pulse Biosciences

0.47

Correlation Coefficient

Salesforce  Pulse Biosciences

Very weak diversification

The 3 months correlation between Salesforce and Pulse is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Pulse Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulse Biosciences and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Pulse Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulse Biosciences has no effect on the direction of Salesforce i.e., Salesforce and Pulse Biosciences go up and down completely randomly.

Pair Corralation between Salesforce and Pulse Biosciences

Considering the 90-day investment horizon Salesforce is expected to under-perform the Pulse Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Salesforce is 2.38 times less risky than Pulse Biosciences. The stock trades about -0.18 of its potential returns per unit of risk. The Pulse Biosciences is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  1,740  in Pulse Biosciences on December 21, 2024 and sell it today you would lose (134.00) from holding Pulse Biosciences or give up 7.7% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Salesforce  vs.  Pulse Biosciences

Salesforce

Risk-Adjusted Performance

Very Weak

Over the last 90 days Salesforce has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pulse Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pulse Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Pulse Biosciences is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Salesforce and Pulse Biosciences

The main advantage of trading using opposite Salesforce and Pulse Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Pulse Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulse Biosciences will offset losses from the drop in Pulse Biosciences' long position.

The idea behind Salesforce and Pulse Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.